Zhu Lab:Lab Members
|Line 96:||Line 96:|
2001 , Development of a recombinant vaccine against hepatitis C virus (HCV): recombinant MVA-HCV live vaccine and combinational rMVA and DNA vaccinefrom the National 863 High Technology Project of ChinaNo. 863-102-07-02-02)
= Societies =
= Societies =
Revision as of 20:40, 19 March 2010
Assistant Professor, Director, Research Laboratory, Digestive Disease and Nutrition Center,
Department of Pediatrics, State University of New York at Buffalo,
3435 Main Street, 422 BRB, Buffalo, NY14214
(716) 829-2191 (Office), (716) 829-2192 (Lab), (716) 829-3585 (Fax), (510) 418-8754 (Cell),
He is responsible for the overall administration and direction of all the research projects.
After graduation from Nankai University, a top research university in China, he was accepted into the graduate program in Shanghai Institute of Biochemistry, the Chinese Academy of Sciences.With his mentors, Professors Guang-Di Li and Yuan Wang, he studied the molecular virology of hepatitis C and developed attenuated live-viral vaccines against hepatitis C, using the modified vaccinia virus Ankara stain as the vector. In this collaborative work, he, Professor Wang’s group and Dr. Gerd Sutter’s group (then in the Institute for Molecular Virology, GSF, Munich, Germany) demonstrated that the invented vaccines are able to elicit protective humoral and cellular immune responses targeting hepatitis C antigens in a murine model.
His postdoc research was all about gastric parietal cell. His major work was focused on a phosphoprotein called ezrin. This protein is discovered in parietal cell and other cells almost simultaneously. Using FRET (fluorescence resonance energy transfer) technique, he studied ezrin conformation in a relatively native state. With his mentor Dr. John G. Forte (University of California, Berkeley), he demonstrated how ezrin phosphorylation regulates the conformation and activity of this protein and the effects on parietal cell acid secretion. His discovery that ezrin phosphorylation is underwent fast turnover may shed light on similar phosphorylation events in different model systems. Besides this, he also participated in the studies of parietal cell membrane trafficking, in collaboration with Dr. Serhan Karvar (University of Southern California).
His current research interests are expanded from gastric parietal cell into the whole GI tract. Together with the dedicated M.D. researchers (Dr. R. Baker, Dr. S. Baker, Dr. H. Hashmi, Dr. D. Gelfond) in DDNC, he has the ambitions to identify biomarkers for NASH and other GI diseases, to better understand the pathophysiology of these diseases for better diagnosis and treatments.
1995,9-2001,8 Shanghai Institute of Biochemistry, the Chinese Academy of Sciences.
Ph. D. obtained in August 2001.
Mentor: Prof. Guangdi Li
Projects: Molecular biology of hepatitis C virus (HCV). Development of an evaluation system for HCV vaccine. Development of a live viral vaccine against HCV.
1991,9-1995,7 Department of biochemistry and molecular biology, Nankai University, China
bachelor’s degree of science, June, 1995. Graduated with honor.
Mentor: Professor Shufang Wang
Project: Effect of agrobacterium tumefacients elicitors on the accumulation of indole alkaloids in catharanthus roseus calli
2009,2- Assistant professor, Director of GI Laboratory, Digestive Disease and Nutrition Center, University at Buffalo, State University of New York
2003,7-2009,1 Postdoctoral fellow, Department of molecular and cell biology,
University of California, Berkeley.
Mentor: Prof. John G. Forte
Projects: Ezrin function in gastric parietal cells, renal proximal tubule cells and small intestine enterocytes: phosphorylation regulation on ezrin conformation and activity. SNARE proteins in gastric parietal cells.
2002,8-2003,7 Postdoctoral fellow, Department of molecular and cell biology,
University of California, Berkeley.
Mentor: Prof. Hsiao-Ping Moore
Project: The constitutive-like secretory pathway of protein secretion from immature secretory granule in pituitary cells.
2001,8-2002,8 Assistant researcher, Shanghai Institute of biochemistry and cell biology, the Chinese Academy of Sciences.
Mentor: Prof. Yuan Wang
Projects: Development of a DNA vaccine against HCV. Induction of apoptosis by HCV E2.
1999,5-2000,10 Visiting scientist, Institute of Molecular Virology, National research center of environment and health, Munich, Germany.
PI: Dr. Gerd Sutter
Project: Development of a live viral vaccine against HCV.
Honors and awards
2009- Invited as Pre-reviewer, the World Journal of Gastroenterology.
2008 Takeda Research Award, the American Physiological Society.
2007-2008 Invited as Science News Editor, the World Journal of Gastroenterology.
1999-2000 Fellowship for visiting scholars, from the International Bureau of the BMBF, Germany.
1995-2001 Fellowship from Shanghai Institute of Biochemistry, the Chinese Academy of Sciences.
1991-1992 First-class scholarship for excellent students, NanKai University.
2001 - 2002, Development of a recombinant vaccine against hepatitis C virus (HCV): recombinant MVA-HCV live vaccine and combinational rMVA and DNA vaccine, from the National 863 High Technology Project of China, No. 863-102-07-02-02. (Role: PI) 2009 - , Regulation of potassium channels in gastric parietal cells, SUNY at Buffalo start-up fund. (Role: PI) 2010 - , Development of an animal model for non-alcoholic steatohepatitis and the use thereof, Peter and Tommy Fund, Inc. (Role: co-PI)
1.The American Physiological Society, Gastrointestinal and Liver Section.
2.The American Society for Cell Biology.
3.The American Association for the Advancement of Science.
4.The American Gastroenterological Association.
Wensheng LIU, Ph.D.
Research Assistant Professor
Dr. Liu received his Ph.D. in Pharmacology from University at Buffalo. He completed his postdoctoral training in Roswell Park Cancer Institute. His research was focused on the molecular mechanisms of breast cancer. Dr. Liu joined our research laboratory in July, 2009. His research interests include membrane trafficking in the gastric parietal cells and the molecular pathogenesis and non-invasive biomarkers of Nonalcoholic Steatohepatitis.
Raza Patel, M.D., MPH
Dr. Patel received his medical degree and masters degree in public health from the University of Utah. He joined the pediatrics residency program at the University at Buffalo and completed residency in June 2008. After which he joined the pediatric gastroenterology, hepatology and nutrition fellowship program at the University at Buffalo in July 2008. His research interests in GI include inflammatory bowel disease, eosinophilic esophagitis, obesity, and variety of liver diseases
Information about other people is coming soon.